Clinical Trials Browser

Phase 3 × INDUSTRY × fosaprepitant × Clear all

NCT05509634 2023-10-27

Clinical Study of HR20013 for Injection in Patients With Malignant Solid Tumors

Phase 3 Completed

Prevention of Nausea and Vomiting Caused by Highly Emetogenic Chemotherapy